CROs might be the engine that keeps preclinical research moving during COVID-19
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
Contrary to the situation for in-house preclinical research, preclinical CROs are largely open for business, according to a survey conducted by Science Exchange.
The survey, conducted March 17-20, included CROs and academic laboratories that are verified providers on Science Exchange Inc.’s service marketplace. The exchange, co-founded by CEO Elizabeth Iorns and COO Dan Knox in 2011, connects scientists with research service providers, including CROs, academic labs and government providers.
In many regions, the restrictions on movement due to COVID-19 have caused
